CAMINNOV, a biotechnology company focused on camelid antibodies, offers state-of-the-art VHH selection and production services including animal immunisation, phage library synthesis, antibody fragment selection, and purification of VHHs.
With innovative strategies (recombinant DNA, cell biology, immunology, screening of VHH libraries), the CAMINNOV team has developed a platform for the production of camel single domain antibodies. Additionally, we can perform engineering and functional characterizations with these antibodies.
CAMINNOV is developing a wide range of phage libraries and camelid antibodies of various proteins (extracellular proteins, matrix proteins, etc) and cells (Neuroblastoma, etc).
Download our documentation: Caminnov